<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 5.3c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: soac%2D20200331.xfr; Date: 2020%2D06%2D16T08:57:09Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80070001 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:SOAC="http://soac.com/20200331">
    <link:schemaRef xlink:href="soac-20200331.xsd" xlink:type="simple" />
    <xbrli:context id="From2020-01-01to2020-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-17_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-17_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_custom_CommonStockAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SOAC:CommonStockAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CommonStockAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SOAC:CommonStockAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_custom_CommonStockAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SOAC:CommonStockAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_custom_CommonStockBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SOAC:CommonStockBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CommonStockBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SOAC:CommonStockBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_custom_CommonStockBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SOAC:CommonStockBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">SOAC:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">SOAC:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_custom_SponsorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SOAC:SponsorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-08_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-01to2020-05-08_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-01</xbrli:startDate>
        <xbrli:endDate>2020-05-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_custom_OrdinaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">SOAC:OrdinaryShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-01to2020-05-08_us-gaap_SubsequentEventMember_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-01</xbrli:startDate>
        <xbrli:endDate>2020-05-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-08_us-gaap_SubsequentEventMember_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-08_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-01to2020-05-08_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-01</xbrli:startDate>
        <xbrli:endDate>2020-05-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-08_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SOAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001798562</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SOAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:AmendmentFlag contextRef="From2020-01-01to2020-03-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2020-01-01to2020-03-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2020-01-01to2020-03-31">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-01-01to2020-03-31">2020-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2020-01-01to2020-03-31">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2020-01-01to2020-03-31">2020</dei:DocumentFiscalYearFocus>
    <dei:EntityCurrentReportingStatus contextRef="From2020-01-01to2020-03-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityShellCompany contextRef="From2020-01-01to2020-03-31">true</dei:EntityShellCompany>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-01-01to2020-03-31">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2020-01-01to2020-03-31">false</dei:EntityExTransitionPeriod>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2020-06-17_us-gaap_CommonClassAMember" unitRef="Shares" decimals="INF">30000000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2020-06-17_us-gaap_CommonClassBMember" unitRef="Shares" decimals="INF">8625000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityInteractiveDataCurrent contextRef="From2020-01-01to2020-03-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityRegistrantName contextRef="From2020-01-01to2020-03-31">Sustainable Opportunities Acquisition Corp.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2020-01-01to2020-03-31">0001798562</dei:EntityCentralIndexKey>
    <dei:EntityFilerCategory contextRef="From2020-01-01to2020-03-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2020-01-01to2020-03-31">true</dei:EntitySmallBusiness>
    <dei:EntityFileNumber contextRef="From2020-01-01to2020-03-31">001-39281</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-01-01to2020-03-31">TX</dei:EntityIncorporationStateCountryCode>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">665135</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">103660</us-gaap:LiabilitiesCurrent>
    <SOAC:NotesPayableRelatedPartiesCurrent contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">146312</SOAC:NotesPayableRelatedPartiesCurrent>
    <SOAC:NotesPayableRelatedPartiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">407596</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">80600</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">111227</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">23060</us-gaap:AccountsPayableCurrent>
    <us-gaap:Assets contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">622097</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">119621</us-gaap:Assets>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">16865</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">15961</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">16865</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">15961</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommonStockValue contextRef="AsOf2020-03-31_us-gaap_CommonClassAMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommonStockValue contextRef="AsOf2020-03-31_us-gaap_CommonClassBMember" unitRef="USD" id="Foot-00-0" decimals="0">863</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-12-31_us-gaap_CommonClassAMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommonStockValue contextRef="AsOf2019-12-31_us-gaap_CommonClassBMember" unitRef="USD" id="Foot-00-1" decimals="0">863</us-gaap:CommonStockValue>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">622097</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">119621</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">-43038</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">15961</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">24137</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">24137</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-9039</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-68038</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_custom_CommonStockAMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2020-03-31_custom_CommonStockAMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_custom_CommonStockBMember" unitRef="USD" id="Foot-00-2" decimals="0">863</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-03-31_custom_CommonStockBMember" unitRef="USD" id="Foot-00-3" decimals="0">863</us-gaap:StockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">-68038</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-9039</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">24137</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">24137</us-gaap:AdditionalPaidInCapital>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2020-03-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-03-31" unitRef="Shares" decimals="INF">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-03-31_us-gaap_CommonClassAMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-03-31_us-gaap_CommonClassBMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-12-31_us-gaap_CommonClassAMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-12-31_us-gaap_CommonClassBMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-03-31_us-gaap_CommonClassAMember" unitRef="Shares" decimals="INF">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-03-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="INF">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-12-31_us-gaap_CommonClassAMember" unitRef="Shares" decimals="INF">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-12-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="INF">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-03-31_us-gaap_CommonClassAMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-03-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="INF">8625000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-12-31_us-gaap_CommonClassAMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-12-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="INF">8625000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-03-31_us-gaap_CommonClassAMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-03-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="INF">8625000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-12-31_us-gaap_CommonClassAMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-12-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="INF">8625000</us-gaap:CommonStockSharesOutstanding>
    <SOAC:ForfeitureIfOverAllotmentOption contextRef="AsOf2020-03-31" unitRef="Shares" decimals="INF">1125000</SOAC:ForfeitureIfOverAllotmentOption>
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">-58999</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2020-01-01to2020-03-31" unitRef="Shares" id="Foot-01-0" decimals="INF">7500000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2020-01-01to2020-03-31" unitRef="USDPShares" decimals="INF">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_custom_CommonStockAMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2020-03-31_custom_CommonStockAMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_custom_CommonStockBMember" unitRef="Shares" id="Foot-00-4" decimals="INF">8625000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-03-31_custom_CommonStockBMember" unitRef="Shares" id="Foot-00-5" decimals="INF">8625000</us-gaap:SharesOutstanding>
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">-58999</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-58999</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-03-31_custom_CommonStockAMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-03-31_custom_CommonStockBMember" unitRef="USD" id="Foot-00-6" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">4175</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">9718</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2020-01-01to2020-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">53456</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <SOAC:DeferredOfferingCostsIncludedInAccountsPayable contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">78449</SOAC:DeferredOfferingCostsIncludedInAccountsPayable>
    <SOAC:DeferredOfferingCostsIncludedInAccruedExpenses contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">326996</SOAC:DeferredOfferingCostsIncludedInAccruedExpenses>
    <SOAC:DeferredOfferingCostsIncludedInNotePayable contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">92856</SOAC:DeferredOfferingCostsIncludedInNotePayable>
    <SOAC:UseOfRetainerForDeferredOfferingCosts contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">-3271</SOAC:UseOfRetainerForDeferredOfferingCosts>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Basis&#13;of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally&#13;accepted in the United States of America ("GAAP") for financial information and pursuant to the rules and regulations&#13;of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management,&#13;the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary&#13;for the fair statement of the balances and results for the periods presented. Operating results for the period for the three months&#13;ended March 31, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and&#13;notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on May 14, 2020 and May 6, 2020,&#13;respectively.&lt;/font&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <SOAC:EmergingGrowthCompanyPolicyTextBlock contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Emerging&#13;Growth Company&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Section&amp;#160;102(b)(1)&#13;of the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act") exempts emerging growth companies from being required&#13;to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities&#13;Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required&#13;to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect&#13;to opt out of the extended transition period and comply with the requirements that apply to&amp;#160;non-emerging&amp;#160;growth companies&#13;but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period,&#13;which means that when a standard is issued or revised and it has different application dates for public or private companies,&#13;the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new&#13;or revised standard.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;This&#13;may make comparison of the Company's financial statements with another public company that is neither an emerging growth&#13;company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because&#13;of the potential differences in accounting standards used.&lt;/font&gt;&lt;/p&gt;</SOAC:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Concentration&#13;of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Financial&#13;instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,&#13;which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At March 31, 2020 and December 31, 2019, the&#13;Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on&#13;such accounts.&lt;/font&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Financial&#13;Instruments&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;fair value of the Company's assets and liabilities, which qualify as financial instruments under the FASB ASC 820, "Fair&#13;Value Measurements" approximates the carrying amounts represented in the balance sheets primarily due to their short-term&amp;#160;nature.&lt;/font&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <SOAC:DeferredOfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Deferred&#13;Offering Costs Associated with the Initial Public Offering&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred&#13;offering costs consist of legal, accounting, underwriting fees and other costs that were directly related to the Initial Public&#13;Offering and that were charged to additional&amp;#160;paid-in&amp;#160;capital upon the completion of the Initial Public Offering in May&#13;2020.&lt;/font&gt;&lt;/p&gt;</SOAC:DeferredOfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Net&#13;Loss Per Ordinary Share&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company complies with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." Net loss&#13;per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. Weighted&#13;average shares were reduced for the effect of an aggregate of 1,125,000 ordinary shares that are subject to forfeiture if the&#13;over-allotment&amp;#160;option is not exercised by the underwriters. At March 31, 2020, the Company did not have any dilutive securities&#13;and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of&#13;the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.&lt;/font&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Income&#13;Taxes&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, "Income Taxes."&#13;Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between&#13;the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets&#13;and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary&#13;differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates&#13;is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary,&#13;to reduce deferred tax assets to the amount expected to be realized.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;FASB&#13;ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement&#13;of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more&#13;likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31,&#13;2020 and December 31, 2019. The Company's management determined that the Cayman Islands is the Company's only major&#13;tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense.&#13;No amounts were accrued for the payment of interest and penalties as of March 31, 2020 and December 31, 2019. The Company is currently&#13;not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.&#13;The Company is subject to income tax examinations by major taxing authorities since inception.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements&#13;in the Cayman Islands or the United States. As such, the Company's tax provision is zero for the period presented.&lt;/font&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:FederalDepositInsuranceCorporationPremiumExpense contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">250000</us-gaap:FederalDepositInsuranceCorporationPremiumExpense>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2020-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <SOAC:AccruedInterest contextRef="AsOf2020-03-31" unitRef="USD" xsi:nil="true" />
    <SOAC:AccruedInterest contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <SOAC:AggregateOrdinarySharesOfSubjectToForfeiture contextRef="AsOf2020-03-31" unitRef="Shares" decimals="INF">1125000</SOAC:AggregateOrdinarySharesOfSubjectToForfeiture>
    <SOAC:AggregateOrdinarySharesOfSubjectToForfeiture contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">1125000</SOAC:AggregateOrdinarySharesOfSubjectToForfeiture>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;4 &amp;#8212; Related Party Transactions&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Founder&#13;Shares&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;December 31, 2019, the Sponsor purchased 8,625,000&amp;#160;shares (the "Founder Shares") of the Company's Class&amp;#160;B&#13;ordinary shares, par value $0.0001 for an aggregate price of $25,000. In March 2020, the Sponsor transferred 30,000 Founder Shares&#13;to each of the Company's independent directors.&amp;#160; The Founder Shares will automatically convert into Class&amp;#160;A ordinary&#13;shares at the time of the Company's initial Business Combination and are subject to certain transfer restrictions, as described&#13;in Note 6. The Sponsor has agreed to forfeit up to 1,125,000 Founder Shares to the extent that the over-allotment&amp;#160;option&#13;is not exercised in full by the underwriter so that the Founder Shares will represent 20.0% of the Company's issued and&#13;outstanding shares after the Initial Public Offering.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Initial Shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until&#13;the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) subsequent to the initial&#13;Business Combination, (x) if the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted&#13;for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within&#13;any 30-trading&amp;#160;day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the&#13;Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company's&#13;shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Private&#13;Placement Warrants&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;Simultaneously&#13;with the closing of the Initial Public Offering, the Company consummated the Private Placement of&amp;#160;&lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9,500,000&amp;#160;&lt;font style="background-color: white"&gt;Private&#13;Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds&#13;of $9.5&amp;#160;million.&amp;#160;&lt;/font&gt;Each Private Placement Warrant is exercisable for one whole Class&amp;#160;A ordinary share at a&#13;price of $11.50 per share.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;A&#13;portion of the proceeds from the sale of the Private Placement Warrants was added to the proceeds from the Initial Public Offering&#13;held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private&#13;Placement Warrants will expire worthless. The Private Placement Warrants will be&amp;#160;non-redeemable&amp;#160;and exercisable on a&#13;cashless basis so long as they are held by the Sponsor or its permitted transferees.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Sponsor and the Company's officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell&#13;any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Related&#13;Party Loans&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;December 31, 2019, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial&#13;Public Offering pursuant to a promissory note (the "Note"). This loan was&amp;#160;non-interest&amp;#160;bearing and payable&#13;upon the completion of the Initial Public Offering. The Company borrowed approximately $146,000 under the Note. Subsequent to&#13;March 31, 2020, the Company borrowed an additional amount of approximately $17,000, for a total amount of approximately $163,000&#13;under the Note and fully repaid this amount on May 8, 2020.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the&#13;Sponsor, or certain of the Company's officers and directors may, but are not obligated to, loan the Company funds as may&#13;be required ("Working Capital Loans"). If the Company completes a Business Combination, the Company would repay the&#13;Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would&#13;be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company&#13;may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the&#13;Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans,&#13;if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either&#13;be repaid upon consummation of a Business Combination, without interest, or, at the lender's discretion, up to $1.5&amp;#160;million&#13;of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per&#13;warrant. The warrants would be identical to the Private Placement Warrants. To date, the Company had no borrowings under the Working&#13;Capital Loans.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Administrative&#13;Support Agreement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company entered into an agreement, commencing on May 8, 2020 through the earlier of the Company's consummation of a Business&#13;Combination and its liquidation, to reimburse the Sponsor a total of $10,000 per month for office space, secretarial and administrative&#13;services.&lt;/font&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets contextRef="From2019-01-01to2019-12-31_custom_FounderSharesMember" unitRef="Shares" decimals="INF">8625000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-03-31_us-gaap_CommonClassAMember" unitRef="USDPShares" decimals="INF">12.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2019-12-31_us-gaap_CommonClassBMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="From2019-01-01to2019-12-31_custom_FounderSharesMember" unitRef="USD" decimals="0">25000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <SOAC:SponsorTransferredFounderShares contextRef="From2020-01-01to2020-03-31_custom_FounderSharesMember" unitRef="Shares" decimals="INF">30000</SOAC:SponsorTransferredFounderShares>
    <SOAC:PercentageOfIssuedAndOutstandingShares contextRef="From2020-01-01to2020-03-31" unitRef="Pure" decimals="INF">0.20</SOAC:PercentageOfIssuedAndOutstandingShares>
    <SOAC:PercentageOfIssuedAndOutstandingShares contextRef="From2020-01-01to2020-03-31_custom_SponsorsMember" unitRef="Pure" decimals="INF">0.20</SOAC:PercentageOfIssuedAndOutstandingShares>
    <SOAC:PrivatePlacementWarrantsDescription contextRef="From2020-01-01to2020-03-31">Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of&#160;9,500,000&#160;Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $9.5&#160;million.&#160;Each Private Placement Warrant is exercisable for one whole Class&#160;A ordinary share at a price of $11.50 per share.</SOAC:PrivatePlacementWarrantsDescription>
    <SOAC:CoverExpenses contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">300000</SOAC:CoverExpenses>
    <SOAC:Borrowings contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">146000</SOAC:Borrowings>
    <SOAC:BorrowedAdditionalAmount contextRef="AsOf2020-05-08_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">17000</SOAC:BorrowedAdditionalAmount>
    <SOAC:PaymentForSecretarialAdministrativeFeesExpense contextRef="From2020-05-01to2020-05-08_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">10000</SOAC:PaymentForSecretarialAdministrativeFeesExpense>
    <us-gaap:BusinessAcquisitionSharePrice contextRef="AsOf2020-03-31" unitRef="USDPShares" decimals="INF">1.00</us-gaap:BusinessAcquisitionSharePrice>
    <SOAC:RepaidAmount contextRef="From2020-05-01to2020-05-08_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">163000</SOAC:RepaidAmount>
    <SOAC:DescriptionOfWarrantRedemption contextRef="From2020-01-01to2020-03-31">&#9679; in whole and not in part; &#9679; at a price of $0.01 per warrant; &#9679; upon a minimum of 30 days' prior written notice of redemption, and &#9679; if, and only if, the closing price of the Company's Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading&#160;day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.</SOAC:DescriptionOfWarrantRedemption>
    <SOAC:DescriptionOfWarrantRedemption contextRef="From2020-01-01to2020-03-31_custom_OrdinaryShareMember">Each whole Public Warrant entitles the holder to purchase one Class&#160;A ordinary share at a price of $11.50 per share. If (x) the Company issues additional Class A ordinary shares or equity-linked&#160;securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company and, (i) in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance, and (ii) without taking into account the transfer of Founder Shares or Private Placement Warrants (including if such transfer is effectuated as a surrender to us and subsequent reissuance by the Company) by the Sponsor in connection with such issuance) (the "Newly Issued Price"), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company's Class A ordinary shares during the 20-trading&#160;day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the "Market Value") is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price discussed below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.</SOAC:DescriptionOfWarrantRedemption>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;7 &amp;#8212; Subsequent Events&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company has evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial&#13;statements were issued. Based upon this review, other than as described in these financial statements, the Company did not identify&#13;any subsequent events that would have required adjustment or disclosure in the financial statements.&lt;/font&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <SOAC:WorkingCapitalLoans contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">1500000</SOAC:WorkingCapitalLoans>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2020-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;6 &amp;#8212; Shareholders' Equity (Deficit)&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Preference&#13;Shares&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company is authorized to issue 1,000,000 preference shares with such designations, voting and other rights and preferences as&#13;may be determined from time to time by the Company's board of directors. As of March 31, 2020 and December 31, 2019, there&#13;were no preference shares issued or outstanding.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Ordinary&#13;Shares&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Class&amp;#160;A&#13;Ordinary Shares&amp;#160;&lt;/i&gt;&lt;/b&gt;&amp;#8212; The Company is authorized to issue 300,000,000 Class&amp;#160;A ordinary shares with a par value&#13;of $0.0001 per share. As of March 31, 2020 and December&amp;#160;31, 2019, there were no Class&amp;#160;A ordinary shares issued or outstanding.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Class&amp;#160;B&#13;Ordinary Shares&amp;#160;&lt;/i&gt;&lt;/b&gt;&amp;#8212; The Company is authorized to issue 30,000,000 Class&amp;#160;B ordinary shares with a par value&#13;of $0.0001 per share. Holders of Class&amp;#160;B ordinary shares are entitled to one vote for each share. As of March 31, 2020 and&#13;December&amp;#160;31, 2019, there were 8,625,000 Class B ordinary shares outstanding.&amp;#160; Of these, an aggregate of up to 1,125,000&amp;#160;shares&#13;are subject to forfeiture to the Company by the Sponsor for no consideration to the extent that the underwriter's over-allotment&amp;#160;option&#13;is not exercised in full or in part, so that the Initial Shareholders will collectively own 20% of the Company's issued&#13;and outstanding ordinary shares after the Initial Public Offering.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Holders&#13;of the Class&amp;#160;A ordinary shares and holders of the Class&amp;#160;B ordinary shares will vote together as a single class on all&#13;matters submitted to a vote of the Company's shareholders except as required by law.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Class&amp;#160;B ordinary shares will automatically convert into Class&amp;#160;A ordinary shares at the time of the initial Business&#13;Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal,&#13;in the aggregate, on an as-converted&amp;#160;basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding&#13;upon completion of the Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued&#13;or issuable upon conversion or exercise of any equity-linked&amp;#160;securities or rights issued or deemed issued, by the Company&#13;in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares&#13;or equity-linked&amp;#160;securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller&#13;in the initial Business Combination and any Private Placement Warrants issued to the Sponsor upon conversion of Working Capital&#13;Loans. Any conversion of Class B ordinary shares will take effect as a compulsory redemption of Class B ordinary shares and an&#13;issuance of Class A ordinary shares as a matter of Cayman Islands law. In no event will the Class B ordinary shares convert into&#13;Class A ordinary shares at a rate of less than one-to-one.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Warrants&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Public&#13;Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the&#13;Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of&amp;#160;(a) 30 days&#13;after the completion of a Business Combination or (b) 12&amp;#160;months from the closing of the Initial Public Offering; provided&#13;in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the Class&#13;A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares&#13;are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the&#13;holder (or the Company permits holders to exercise their warrants on a cashless basis under certain circumstances). The Company&#13;has agreed that as soon as practicable, but in no event later than 20 business days, after the closing of a Business Combination,&#13;the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary&#13;shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until&#13;the warrants expire or are redeemed. If a registration statement covering the Class A ordinary shares issuable upon exercise of&#13;the warrants is not effective by the 60&lt;sup&gt;th&lt;/sup&gt;&amp;#160;day after the closing of the initial Business Combination, warrant holders&#13;may, until such time as there is an effective registration statement and during any period when the Company will have failed to&#13;maintain an effective registration statement, exercise warrants on a "cashless basis" in accordance with Section 3(a)(9)&#13;of the Securities Act or another exemption. The Public Warrants will expire five years after the completion of a Business Combination&#13;or earlier upon redemption or liquidation.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Each&#13;whole Public Warrant entitles the holder to purchase one Class&amp;#160;A ordinary share at a price of $11.50 per share. If (x) the&#13;Company issues additional Class A ordinary shares or equity-linked&amp;#160;securities for capital raising purposes in connection&#13;with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary&#13;share (with such issue price or effective issue price to be determined in good faith by the Company and, (i) in the case of any&#13;such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates,&#13;as applicable, prior to such issuance, and (ii) without taking into account the transfer of Founder Shares or Private Placement&#13;Warrants (including if such transfer is effectuated as a surrender to us and subsequent reissuance by the Company) by the Sponsor&#13;in connection with such issuance) (the "Newly Issued Price"), (y) the aggregate gross proceeds from such issuances&#13;represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business&#13;Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted&#13;average trading price of the Company's Class A ordinary shares during the 20-trading&amp;#160;day period starting on the trading&#13;day prior to the day on which the Company consummates its initial Business Combination (such price, the "Market Value")&#13;is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the&#13;higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price discussed below will&#13;be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants):&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;in&#13;    whole and not in part;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;at&#13;    a price of $0.01 per warrant;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;upon&#13;    a minimum of 30 days' prior written notice of redemption, and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;if,&#13;    and only if, the closing price of the Company's Class A ordinary shares equals or exceeds $18.00 per share (as adjusted&#13;    for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within&#13;    a 30-trading&amp;#160;day period ending on the third trading day prior to the date on which the Company sends the notice of redemption&#13;    to the warrant holders.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;If&#13;the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise&#13;the Public Warrants to do so on a "cashless basis," as described in the warrant agreement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except&#13;that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants will not&#13;be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited&#13;exceptions. Additionally, the Private Placement Warrants will be&amp;#160;non-redeemable&amp;#160;so long as they are held by the initial&#13;purchasers or such purchasers' permitted transferees. If the Private Placement Warrants are held by someone other than the&#13;Initial Shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable&#13;by such holders on the same basis as the Public Warrants.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Additionally,&#13;in no event will the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business&#13;Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants&#13;will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company's&#13;assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.&lt;/font&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">58999</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;1 &amp;#8212; Description of Organization and Business Operations&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Sustainable&#13;Opportunities Acquisition Corp. (the "Company") is a newly organized blank check company incorporated as a Cayman&#13;Islands exempted company on December&amp;#160;18, 2019. The Company was incorporated for the purpose of effecting a merger, share&#13;exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities&#13;(the "Business Combination"). The Company has not selected any Business Combination target and the Company has not,&#13;nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any Business Combination target.&#13;The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth&#13;companies.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of March 31, 2020, the Company had not commenced any operations. All activity for the period from December&amp;#160;18, 2019 (inception)&#13;through March 31, 2020 relates to the Company's formation and the initial public offering described below. The Company will&#13;not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company&#13;will generate&amp;#160;non-operating&amp;#160;income in the form of interest income on cash and cash equivalents from the proceeds derived&#13;from the Initial Public Offering (as defined below). The Company has selected December&amp;#160;31 as its fiscal year end.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company's sponsor is Sustainable Opportunities Holdings LLC, a Delaware limited liability company (the "Sponsor").&amp;#160;&lt;font style="background-color: white"&gt;The&#13;registration statement for the Company's Initial Public Offering was declared effective on May 5, 2020. On&amp;#160;&lt;/font&gt;May&#13;8, 2020&lt;font style="background-color: white"&gt;, the Company consummated its&amp;#160;Initial Public Offering of&amp;#160;&lt;/font&gt;30,000,000&amp;#160;&lt;font style="background-color: white"&gt;units&#13;(the "Units" and, with respect to the Class&amp;#160;A ordinary shares included in the Units being offered, the "Public&#13;Shares") at $10.00 per Unit, generating gross proceeds of&amp;#160;$300.0&amp;#160;million, and incurring offering costs of approximately&#13;$17.4 million, inclusive of $10.5&amp;#160;million in deferred underwriting commissions (Note&amp;#160;5).&amp;#160;&lt;/font&gt;The Company has&#13;granted the underwriter a 45-day option to purchase up to an additional 4,500,000 Units at the Initial Public Offering price to&#13;cover over-allotments, if any.&amp;#160;&amp;#160;&lt;font style="background-color: white"&gt;To date, the over-allotment option has not been&#13;exercised yet.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;Simultaneously&#13;with the closing of the Initial Public Offering, the Company consummated the private placement ("Private Placement")&#13;of&amp;#160;&lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9,500,000 warrants&amp;#160;&lt;font style="background-color: white"&gt;(each,&#13;a "Private Placement Warrant" and collectively, the "Private Placement Warrants") at a price of $1.00&#13;per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $9.5&amp;#160;million (Note 4).&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;Upon&#13;the closing of the Initial Public Offering and the Private Placement, $300.0&amp;#160;million ($10.00 per Unit) of the net proceeds&#13;of the sale of the Units in the Initial Public Offering and the Private Placement were placed&amp;#160;in a trust account (the "Trust&#13;Account"),&lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;located in the United States&#13;at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer&amp;#160;&amp;#38; Trust Company acting as trustee, and invested only&#13;in U.S. government securities, within the meaning set forth in Section&amp;#160;2(a)(16) of the Investment Company Act, with a maturity&#13;of 185 days or less or in any open-ended&amp;#160;investment company that holds itself out as a money market fund selected by the&#13;Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule&amp;#160;2a-7&amp;#160;of the Investment Company Act, as&#13;determined by the Company, until the earlier of: (i)&amp;#160;the completion of a Business Combination and (ii)&amp;#160;the distribution&#13;of the Trust Account as described below.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company's management has broad discretion with respect to the specific application of the net proceeds of the Initial Public&#13;Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied&#13;generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business&#13;Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market&#13;value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions&#13;and taxes payable on income earned on the Trust Account) at the time of the signing of the agreement to enter into the initial&#13;Business Combination. However, the Company will only complete a Business Combination if the post-transaction&amp;#160;company owns&#13;or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the&#13;target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended&#13;(the "Investment Company Act").&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company will provide the holders (the "Public Shareholders") of its Class&amp;#160;A ordinary shares, par value $0.0001&#13;per share sold in the Initial Public Offering (the "Public Shares") with the opportunity to redeem all or a portion&#13;of their Public Shares upon the completion of a Business Combination either (i)&amp;#160;in connection with a shareholder meeting&#13;called to approve the Business Combination or (ii)&amp;#160;by means of a tender offer. The decision as to whether the Company will&#13;seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion.&#13;The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust&#13;Account (initially anticipated to be $10.00 per Public Share). The&amp;#160;per-share&amp;#160;amount to be distributed to Public Shareholders&#13;who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter&#13;(as discussed in Note 5). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the&#13;completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board's ("FASB")&#13;Accounting Standards Codification ("ASC") Topic 480 "Distinguishing Liabilities from Equity." In such&#13;case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon&#13;such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination.&#13;If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other&#13;legal reasons, the Company will, pursuant to the amended and restated memorandum and articles of association, which the Company&#13;adopted upon the consummation of the Initial Public Offering (the "Amended and Restated Memorandum and Articles of Association")&#13;conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission ("SEC")&#13;and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of&#13;the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the&#13;Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the&#13;tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they&#13;vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination,&#13;the Initial Shareholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public&#13;Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders&#13;have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion&#13;of a Business Combination.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Notwithstanding&#13;the foregoing, the Amended and Restated Memorandum and Articles of Association will provide that a Public Shareholder, together&#13;with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a "group"&#13;(as defined under Section&amp;#160;13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), will be&#13;restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class&amp;#160;A ordinary shares&#13;sold in the Initial Public Offering, without the prior consent of the Company.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company's Sponsor, officers and directors (the "Initial Shareholders") have agreed not to propose an amendment&#13;to the Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company's&#13;obligation to provide holders of its Public Shares the right to have their shares redeemed in connection with its initial business&#13;combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 18&amp;#160;months&#13;from the closing of the Initial Public Offering, or November 8, 2021 (the "Combination Period") unless the Company&#13;provides the Public Shareholders with the opportunity to redeem their Class&amp;#160;A ordinary shares in conjunction with any such&#13;amendment.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;If&#13;the Company is unable to complete a Business Combination within the Combination Period, the Company will: (i) cease all operations&#13;except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter,&#13;redeem the Public Shares, at a per-share&amp;#160;price, payable in cash, equal to the aggregate amount then on deposit in the Trust&#13;Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay for&#13;its tax obligations, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding&amp;#160;Public&#13;Shares, which redemption will completely extinguish Public Shareholders' rights as shareholders (including the right to&#13;receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject&#13;to the approval of the remaining shareholders and the Company's board of directors, liquidate and dissolve, subject in the&#13;case of clauses (ii) and (iii), to the Company's obligations under Cayman Islands law to provide for claims of creditors&#13;and the requirements of other applicable law.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Initial Shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to&#13;complete a Business Combination within the Combination Period. However, if the Initial Shareholders acquire Public Shares in or&#13;after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such&#13;Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriter has agreed&#13;to waive its rights to its deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does&#13;not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the&#13;other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such&#13;distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust&#13;Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the&#13;Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services&#13;rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into&#13;a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims&#13;by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust&#13;Account or to any claims under the Company's indemnity of the underwriter of the Initial Public Offering against certain&#13;liabilities, including liabilities under the Securities Act of 1933, as amended (the "Securities Act"). Moreover,&#13;in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible&#13;to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will&#13;have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective&#13;target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right,&#13;title, interest or claim of any kind in or to monies held in the Trust Account.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Liquidity&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of&amp;#160;March 31, 2020, the Company had no cash and working capital deficit of approximately&amp;#160;$648,000.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt; background-color: white"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company's liquidity needs up to March 31, 2020 have been satisfied through a $25,000 contribution from the Sponsor in exchange&#13;for the issuance of the Founder Shares to the Sponsor and the advancement of funds by the Sponsor of approximately $146,000 under&#13;the Note (see Note 4) to the Company to cover for offering costs in connection with the Initial Public Offering. Subsequent to&#13;March 31, 2020, the Company borrowed an additional amount of approximately $17,000, for a total amount of approximately $163,000&#13;under the Note. The Company fully repaid the Note on May 8, 2020. Subsequent to the consummation of the Initial Public Offering&#13;and the Private Placement Warrants, the Company's liquidity has been satisfied through the proceeds from the consummation&#13;of the Private Placement not held in the Trust Account of approximately $3.1 million. In addition, in order to finance transaction&#13;costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company's&#13;officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). As of March 31,&#13;2020, there were no amounts outstanding under any Working Capital Loans.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt; background-color: white"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Based&#13;on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor&#13;or an affiliate of the Sponsor, or certain of the Company's officers and directors to meet its needs through the earlier&#13;of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these&#13;funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing&#13;due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or&#13;acquire, and structuring, negotiating and consummating the Business Combination.&lt;/font&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="From2020-05-01to2020-05-08_us-gaap_SubsequentEventMember_us-gaap_IPOMember" unitRef="USD" decimals="0">300000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="From2020-05-01to2020-05-08_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember" unitRef="USD" decimals="0">9500000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2020-05-08_us-gaap_SubsequentEventMember_us-gaap_IPOMember" unitRef="USDPShares" decimals="INF">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2020-05-08_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember" unitRef="USDPShares" decimals="INF">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2020-05-08_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:DeferredCostsCurrent contextRef="AsOf2020-05-08_us-gaap_SubsequentEventMember_us-gaap_IPOMember" unitRef="USD" decimals="0">17400000</us-gaap:DeferredCostsCurrent>
    <SOAC:ConsummatedInitialPublicOfferingShares contextRef="From2020-05-01to2020-05-08_us-gaap_SubsequentEventMember_us-gaap_IPOMember" unitRef="Shares" decimals="INF">30000000</SOAC:ConsummatedInitialPublicOfferingShares>
    <SOAC:DeferredUnderwritingCommissions contextRef="From2020-05-01to2020-05-08_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">10500000</SOAC:DeferredUnderwritingCommissions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2020-01-01to2020-03-31_us-gaap_IPOMember">P45D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharesIssued contextRef="AsOf2020-03-31_us-gaap_IPOMember" unitRef="Shares" decimals="INF">4500000</us-gaap:SharesIssued>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2020-05-01to2020-05-08_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember" unitRef="Shares" decimals="INF">9500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <SOAC:ClosingInitialPublicOfferingDescription contextRef="From2020-01-01to2020-03-31">Upon the closing of the Initial Public Offering and the Private Placement, $300.0 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement were placed in a trust account (the &#8220;Trust Account&#8221;), located in the United States at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer &amp; Trust Company acting as trustee, and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</SOAC:ClosingInitialPublicOfferingDescription>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="AsOf2020-03-31" unitRef="Pure" decimals="INF">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <SOAC:DescriptionOfPublicShareholders contextRef="From2020-01-01to2020-03-31">The Company will provide the holders (the &#8220;Public Shareholders&#8221;) of its Class A ordinary shares, par value $0.0001 per share sold in the Initial Public Offering (the &#8220;Public Shares&#8221;) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share).</SOAC:DescriptionOfPublicShareholders>
    <SOAC:AmountOfTangibleAssests contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">5000001</SOAC:AmountOfTangibleAssests>
    <SOAC:RedeemingSharesPercentage contextRef="From2020-01-01to2020-03-31" unitRef="Pure" decimals="INF">0.15</SOAC:RedeemingSharesPercentage>
    <SOAC:PercentageOfRedemptionOfCompanysOutstandingPublicShares contextRef="From2020-01-01to2020-03-31" unitRef="Pure" decimals="INF">1.00</SOAC:PercentageOfRedemptionOfCompanysOutstandingPublicShares>
    <SOAC:BusinessCombinationTerm contextRef="From2020-01-01to2020-03-31">P18M</SOAC:BusinessCombinationTerm>
    <us-gaap:BusinessCombinationControlObtainedDescription contextRef="From2020-01-01to2020-03-31">(i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay for its tax obligations, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders&#8217; rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company&#8217;s board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company&#8217;s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.</us-gaap:BusinessCombinationControlObtainedDescription>
    <SOAC:WorkingCapitalDeficit contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">648000</SOAC:WorkingCapitalDeficit>
    <SOAC:ContributionAmount contextRef="From2020-01-01to2020-03-31_custom_SponsorMember" unitRef="USD" decimals="0">25000</SOAC:ContributionAmount>
    <SOAC:BorrowingAmount contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">17000</SOAC:BorrowingAmount>
    <SOAC:AddditionalAmount contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">163000</SOAC:AddditionalAmount>
    <SOAC:PrivatePlacementHeldInTrustAccount contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">3100000</SOAC:PrivatePlacementHeldInTrustAccount>
    <SOAC:InitialPublicOfferingTextBlock contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;3 &amp;#8212; Initial Public Offering&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;On&amp;#160;&lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;May&#13;8, 2020&lt;font style="background-color: white"&gt;, the Company consummated its&amp;#160;Initial Public Offering of&amp;#160;&lt;/font&gt;30,000,000&amp;#160;&lt;font style="background-color: white"&gt;Units&#13;at $10.00 per Unit, generating gross proceeds of&amp;#160;$300.0&amp;#160;million, and incurring offering costs of approximately $17.4&#13;million, inclusive of $10.5&amp;#160;million in deferred underwriting commissions.&amp;#160;&lt;/font&gt;Each Unit consists of one Class&amp;#160;A&#13;ordinary share and&amp;#160;one-half&amp;#160;of one redeemable warrant (each, a "Public Warrant"). Each Public Warrant entitles&#13;the holder to purchase one Class&amp;#160;A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 6).&lt;/font&gt;&lt;/p&gt;</SOAC:InitialPublicOfferingTextBlock>
    <SOAC:DescriptionOfInitialPublicOffering contextRef="From2020-05-01to2020-05-08_us-gaap_SubsequentEventMember_us-gaap_IPOMember">Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (each, a &#8220;Public Warrant&#8221;). Each Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 6).</SOAC:DescriptionOfInitialPublicOffering>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;5 &amp;#8212; Commitments&amp;#160;&amp;#38; Contingencies&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Registration&#13;and Shareholder Rights&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans,&#13;if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to Class&amp;#160;A&#13;ordinary shares) pursuant to a registration and shareholder rights agreement. These holders will be entitled to certain demand&#13;and "piggyback" registration rights. However, the registration and shareholder rights agreement provides that the&#13;Company will not permit any registration statement filed under the Securities Act to become effective until the termination of&#13;the applicable&amp;#160;lock-up&amp;#160;period for the securities to be registered. The Company will bear the expenses incurred in connection&#13;with the filing of any such registration statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Underwriting&#13;Agreement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company granted the underwriter a&amp;#160;45-day&amp;#160;option from the date of the final prospectus relating to the Initial Public&#13;Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit, less the underwriting&#13;discounts and commissions. To date, the&amp;#160;&lt;font style="background-color: white"&gt;over-allotment option has not been exercised&#13;yet.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;underwriter was entitled to an underwriting discount of $0.20 per unit, or $6.0&amp;#160;million in the aggregate paid upon the closing&#13;of the Initial Public Offering. In addition, $0.35 per unit, or $10.5&amp;#160;million in the aggregate will be payable to the underwriter&#13;for deferred underwriting commissions. The deferred underwriting commissions will become payable to the underwriter from the amounts&#13;held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting&#13;agreement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;If&#13;the over-allotment option is exercised in full, the underwriter will be entitled to an aggregate of $900,000 in fees payable upon&#13;closing and an additional deferred underwriting commissions of approximately $1.58 million.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Risk&#13;and Uncertainties&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;January 30, 2020, the World Health Organization ("WHO") announced a global health emergency because of a new strain&#13;of coronavirus (the "COVID-19 outbreak"). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based&#13;on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve. The impact of the COVID-19&#13;outbreak on the Company's results of operations, financial position and cash flows will depend on future developments, including&#13;the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the COVID-19&#13;outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets&#13;and/or the overall economy are impacted for an extended period, the Company's results of operations, financial position&#13;and cash flows may be materially adversely affected. Additionally, the Company's ability to complete an Initial Business&#13;Combination may be materially adversely affected due to significant governmental measures being implemented to contain the COVID-19&#13;outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may&#13;limit the Company's ability to have meetings with potential investors or affect the ability of a potential target company's&#13;personnel, vendors and service providers to negotiate and consummate an Initial Business Combination in a timely manner. The Company's&#13;ability to consummate an Initial Business Combination may also be dependent on the ability to raise additional equity and debt&#13;financing, which may be impacted by the COVID-19 outbreak and the resulting market downturn. The financial statements do not include&#13;any adjustments that might result from the outcome of this uncertainty.&lt;/font&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <SOAC:DescriptionOfUnderwritingAgreement contextRef="From2020-01-01to2020-03-31">The underwriter was entitled to an underwriting discount of $0.20 per unit, or $6.0 million in the aggregate paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $10.5 million in the aggregate will be payable to the underwriter for deferred underwriting commissions. The deferred underwriting commissions will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.</SOAC:DescriptionOfUnderwritingAgreement>
    <SOAC:DeferredUnderwritingCommission contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">1580000</SOAC:DeferredUnderwritingCommission>
    <SOAC:UnderwriterFeesPayable contextRef="From2020-01-01to2020-03-31" unitRef="USD" decimals="0">900000</SOAC:UnderwriterFeesPayable>
    <SOAC:SharesIssuedPricePerShares contextRef="AsOf2020-03-31_us-gaap_IPOMember" unitRef="USDPShares" decimals="INF">10.00</SOAC:SharesIssuedPricePerShares>
    <SOAC:ShareIssuedPricePerShare contextRef="AsOf2020-03-31" unitRef="USDPShares" decimals="INF">10.00</SOAC:ShareIssuedPricePerShare>
    <SOAC:ShareIssuedPricePerShare contextRef="AsOf2020-03-31_custom_SponsorMember" unitRef="USDPShares" decimals="INF">10.00</SOAC:ShareIssuedPricePerShare>
    <SOAC:AdvancementFunds contextRef="AsOf2020-03-31_custom_SponsorMember" unitRef="USD" decimals="0">146000</SOAC:AdvancementFunds>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:Cash contextRef="AsOf2020-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;2 &amp;#8212; Summary of Significant Accounting Policies&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Basis&#13;of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally&#13;accepted in the United States of America ("GAAP") for financial information and pursuant to the rules and regulations&#13;of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management,&#13;the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary&#13;for the fair statement of the balances and results for the periods presented. Operating results for the period for the three months&#13;ended March 31, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The accompanying&#13;unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto&#13;included in the Form 8-K and the final prospectus filed by the Company with the SEC on May 14, 2020 and May 6, 2020, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Emerging&#13;Growth Company&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Section&amp;#160;102(b)(1)&#13;of the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act") exempts emerging growth companies from being required&#13;to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities&#13;Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required&#13;to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect&#13;to opt out of the extended transition period and comply with the requirements that apply to&amp;#160;non-emerging&amp;#160;growth companies&#13;but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period,&#13;which means that when a standard is issued or revised and it has different application dates for public or private companies,&#13;the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new&#13;or revised standard.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;This&#13;may make comparison of the Company's financial statements with another public company that is neither an emerging growth&#13;company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because&#13;of the potential differences in accounting standards used.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Concentration&#13;of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Financial&#13;instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,&#13;which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At March 31, 2020 and December 31, 2019, the&#13;Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on&#13;such accounts.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Financial&#13;Instruments&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;fair value of the Company's assets and liabilities, which qualify as financial instruments under the FASB ASC 820, "Fair&#13;Value Measurements" approximates the carrying amounts represented in the balance sheets primarily due to their short-term&amp;#160;nature.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Use&#13;of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;The&#13;preparation of the balance sheets in conformity with GAAP requires the Company's management to make estimates and assumptions&#13;that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of&#13;the balance sheets. Actual results could differ from those estimates.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Deferred&#13;Offering Costs Associated with the Initial Public Offering&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred&#13;offering costs consist of legal, accounting, underwriting fees and other costs that were directly related to the Initial Public&#13;Offering and that were charged to additional&amp;#160;paid-in&amp;#160;capital upon the completion of the Initial Public Offering in May&#13;2020.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Net&#13;Loss Per Ordinary Share&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company complies with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." Net loss&#13;per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. Weighted&#13;average shares were reduced for the effect of an aggregate of 1,125,000 ordinary shares that are subject to forfeiture if the&#13;over-allotment&amp;#160;option is not exercised by the underwriters. At March 31, 2020, the Company did not have any dilutive securities&#13;and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of&#13;the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Income&#13;Taxes&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, "Income Taxes."&#13;Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between&#13;the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets&#13;and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary&#13;differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates&#13;is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary,&#13;to reduce deferred tax assets to the amount expected to be realized.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;FASB&#13;ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement&#13;of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more&#13;likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31,&#13;2020 and December 31, 2019. The Company's management determined that the Cayman Islands is the Company's only major&#13;tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense.&#13;No amounts were accrued for the payment of interest and penalties as of March 31, 2020 and December 31, 2019. The Company is currently&#13;not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.&#13;The Company is subject to income tax examinations by major taxing authorities since inception.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements&#13;in the Cayman Islands or the United States. As such, the Company's tax provision is zero for the period presented.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Recent&#13;Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company's management does not believe that any recently issued, but not yet effective, accounting standards, if currently&#13;adopted, would have a material effect on the financial statements.&lt;/font&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Use&#13;of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;The&#13;preparation of the balance sheets in conformity with GAAP requires the Company's management to make estimates and assumptions&#13;that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of&#13;the balance sheets. Actual results could differ from those estimates.&lt;/font&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2020-01-01to2020-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Recent&#13;Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company's management does not believe that any recently issued, but not yet effective, accounting standards, if currently&#13;adopted, would have a material effect on the financial statements.&lt;/font&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:DeferredCosts contextRef="AsOf2020-03-31" unitRef="USD" decimals="0">605232</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">103660</us-gaap:DeferredCosts>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2020-01-01to2020-03-31" unitRef="USD" xsi:nil="true" />
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-1" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-2" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-3" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-4" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-5" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-6" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-01" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-0" xlink:label="Foot-01_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-01_loc" xlink:to="Footnote-02" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">This number includes up to 1,125,000 shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4).</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-02" xml:lang="en-US">This number excludes an aggregate of up to 1,125,000 shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4).</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>

